Stephan Lorenz

Stephan Lorenz serves as CEO at Iscador AG. Iscador AG operates in the pharmaceuticals sector with approximately 46.0 employees. The company is headquartered in Basel, Basel-Stadt.

Industry & Role Insights

• • MessageCEO tracks 1,288 executives in the pharmaceuticals sector.
• • 259 executive contacts are available in Basel-Stadt.
• • Our database includes 201,465 c suite-level executives.

Outlook MailChimp SPF Microsoft Office 365 reCAPTCHA Gravity Forms YouTube WordPress.org Google Tag Manager Mobile Friendly Bootstrap Framework AI Looker Render

pharmaceutical manufacturing mistletoe therapy integrative cancer treatment plant-based preparations holistic approach medical support quality of life complementary medicine natural remedies oncology care research & development anthroposophic medicine clinical evidence phytotherapy patient-centered care immune system support cancer research medical consultations healthcare professionals remedy production patient education therapeutic adherence integrative oncology natural medicine therapeutic outcomes information materials healthcare partnerships pharmacy support medical advice subcutaneous injection natural ingredients clinical studies health conditions oncology specialists sustainability human-centered treatment patient information pain relief treatment planning cancer management services for patients infoline for professionals event participation diagnostic tools therapy recommendations cancer care solutions emotional support educational resources professional networks pharmaceuticals medical environmental services renewables & environment

YM

Yathendra Madineni Chief Executive Officer at 4C Pharma Solutions

RB

Ronan Brown Chief Operating Officer at 4G Clinical

HK

Hitoshi Kamiya Chief Executive Officer at A2 Healthcare Corporation

LJ

Lars Jensen CEO at A-apoteket

TL

Tien Lee CEO at Aardvark Therapeutics, Inc.

Outreach Guidance — pharmaceuticals Sector

Executives like Stephan Lorenz in the pharmaceuticals sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at Iscador AG.

Stephan Lorenz's Position in the MessageCEO Database

• •Stephan Lorenz is 1 of 1 verified executive contact we track at Iscador AG.
• •1,240 verified executive contacts in pharmaceuticals are in the MessageCEO database.
• •255 verified executive contacts in Basel-Stadt are in the database.
• •13 verified contacts work at pharmaceuticals companies in the 46.0 employee range (same size as Iscador AG).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated October 2026.

How do I reach Stephan Lorenz directly?

Stephan Lorenz's verified email address is available to MessageCEO Pro subscribers. They currently serve as CEO at Iscador AG. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Stephan Lorenz work for?

Stephan Lorenz is CEO at Iscador AG, a company in the pharmaceuticals sector with 46.0 employees. The company is based in Basel, Basel-Stadt.

Can I pitch or sell to Stephan Lorenz?

As CEO at Iscador AG, Stephan Lorenz is a key decision-maker in the pharmaceuticals sector. MessageCEO Pro gives you verified email to reach Stephan Lorenz directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Stephan Lorenz in?

Stephan Lorenz works in the pharmaceuticals industry as CEO at Iscador AG. MessageCEO provides verified contact information for executives across all major industries.

Is Stephan Lorenz's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Stephan Lorenz's profile is kept up-to-date with the latest available information.

Last updated: October 31, 2026